"The undersigned members of the Diabetes Advocacy Alliance (DAA) are writing to express our support for various provisions of the Notice of Benefit and Payment Parameters (NBPP) for 2025, specifically moving from USP Medicare Model Guidelines (MMG) to the USP Drug Classification (USP DC) system for use in the essential health benefit (EHB) package described in section 1302(a) of the Affordable Care Act (ACA). As you may know, there are about 38 million people living with diabetes in the United States, and it is estimated that about 98 million U.S. adults have prediabetes.1 We appreciate that CMS is considering moving to the USP DC, as such a move would have great benefits for the millions of people living with prediabetes and diabetes."
